ID-CRU: In The News

Researchers at Washington University School of Medicine in St. Louis and the Saint Louis University Center for Vaccine Development have joined the effort to find a COVID-19 vaccine that can prevent the illness. Researchers at the universities expect to enroll about 3,000 participants in several COVID-19 vaccine trials, with each school participating in different trials. (Photo: Getty Images)

Rachel Presti, MD, PhD leads Washington University effort to conduct COVID-19 vaccine trials in collaboration with Saint Louis University

Rachel Presti, MD, PhD, associate professor and investigator at the IDCRU/ACTU for HPTN 083 says study results are a game changer for HIV prevention

HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV

Rachel Presti, MD, PhD and the Infectious Diseases Clinical Research Team collaborate in $3.4 million effort to make a better flu vaccine

The flu vaccine’s protection against influenza only lasts a few months. Researchers at Washington University School of Medicine in St. Louis are studying why immunity elicited by the flu vaccine wanes so rapidly. Their goal is to make a better, longer-lasting flu vaccine. (Getty Images)

Patients with COVID-19 donate specimens to advance research efforts

Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment

COVID-19 survivors needed to donate blood plasma